A Philips logo stands outside of the new global Philips Headquarters in Amsterdam, Netherlands, October 16, 2025. REUTERS
Feb 10 – Dutch healthtech company Philips on Tuesday forecast comparable sales growth of 3% to 4.5% for 2026, below the roughly 4.5% expected previously.
The company also said that it expects to generate free cash flow of between 1.3 billion and 1.5 billion euros.
CEO Roy Jakobs said in December that the impact of U.S. tariffs was expected to “almost double” this year, pressuring margins despite ongoing cost cuts.
Reporting by Leo Marchandon in Gdansk
